HOME  >  Company Introduction

Core personnel

Core personnel


배원기 상무이사

Jason Bae, Executive Director (Chief Operating Officer)

  • Visiting Scholar, Washington State University, College of Veterinary Medicine, USA
  • Ph.D., Seoul National University, College of Veterinary Medicine
  • Post-Doc., Seoul National University, College of Veterinary Medicine
  • Director, Seegene, Inc. (Int’l sales, business development, corporate strategy, B2B, strategic business unit, executive secretary of CEO)
  • Manager, Standard Diagnostics, Inc. (Int’l sales and business development)
김민정 이사

Minjeong Kim, Director of IP Group (Patent Attorney, Pharmacist)

  • B.S. Pharm., Pusan National University, College of Pharmacy
  • Director of HANALL BIOPHARMA Strategic Planning Center
  • Patent Attorney, Hanmi Pharmarceutical Legal Affairs Team
김택승 이사

Taekseung Kim, Director of Regulatory Affairs

  • M.S., B.S., Chung-Ang University, Molecular Biology
  • Director of RA, Huons Global
  • Team Leader of RA, ISU ABXIS (RA and Clinical Trials)
  • Senior Researcher, R&D of Biosimilar, Antibody, Recombinant Therapeutic, ISU ABXIS
  • Senior Researcher, R&D of Bone Marrow Stem Cell and Adipose-derived Stem Cell Therapeutic, Anterogen
이은호 상무이사

Eun-Ho Lee, Executive Director (Research and Development)

  • M.S., B.S., Sogang University, Dept. of Life Sciences
  • Ph.D., Dankook University, College of Medicine (Pharmacology Lab)
  • CTO, Clinical Development, Generys Korea
  • Team Leader, Oscotec (leading Preclinical Development Projects for Rheumatoid Arthritis & Parkinson’s disease)
  • Senior researcher, SK Biopharmaceuticals (an inventor of the patent for Cenobamate (NDA acceptance, 2019, US))
오언주 박사

Eonju Oh, Senior Researcher (R&D)

  • Ph.D., Hanyang University, Dept. of Bioengineering (Gene Therapy Lab)
  • 16 SCI Journal Publications on Oncolytic Adenovirus & Antitumor Immune Response

Advisory committee member

추연성 고문

Youn Sung Choo, Advisor

  • M.S., B.S., College of Pharmacy, Seoul National University
  • Ph.D., College of Pharmacy, University of Illinois
  • Senior Associate Scientist, Hoechst Marrion Roussel (HMR), US
  • Head, R&D, LG Life Sciences
  • Director, Pharmaceutical Business, LG Life Sciences
  • Project Leader, LG Life Sciences (leading US FDA approval of a new drug (Factive) for the first time in Korea)